Interpretation of the 2022 edition of"guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China"
10.16139/j.1007-9610.2023.06.05
- VernacularTitle:2022版《中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》解读
- Author:
Bojin XU
1
;
Wenfang PENG
;
Shan HUANG
Author Information
1. 上海交通大学医学院附属同仁医院内分泌科,上海 200336
- Keywords:
Thyrotoxicosis;
Hyperthyroidism;
Thyroid crisis;
Graves ophthalmopathy;
Guide Interpretation
- From:
Journal of Surgery Concepts & Practice
2023;28(6):512-519
- CountryChina
- Language:Chinese
-
Abstract:
"Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China"(2022)(referred to as the"guidelines")was officially published in August 2022 in the Chinese Journal of Endocrine Metabolism.These guidelines have been extensively updated from the 2007 version,with 15 sections covering the etiology,clinical manifestations,diagnosis,evaluation,and treatment of hyperthyroidism,as well as the management of specific types of thyrotoxicosis.The new version guidelines proposed 107 recommended opinions supported by stronger evidence,offering comprehensive and reliable guidance for clinical doctors and medical professionals dealing with thyrotoxicosis.This article aimed to extract the key points and recommended strategies from the guidelines to help clinical doctors better understand and apply the latest guiding principles.
